CVM

Cel Sci Stock Price

14.38
-0.16 (-1.1%)
Upgrade to Real-Time
Regular Market
14.38
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Cel Sci Corporation New CVM AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.16 -1.1% 14.38 14.13 14.90 14.80 14.54 15:57:40
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,576 421,958 $ 14.38 $ 6,068,992 836,667 5.75 - 22.00
Last Trade Time Type Quantity Stock Price Currency
15:57:33 100 $ 14.38 USD

Cel Sci Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 534.02M 37.63M 35.98M $ - $ - -0.70 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
7.22M $ - 0.00% - -

more financials information »

Cel Sci News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CVM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week13.8414.9913.5714.18509,1300.543.9%
1 Month13.7817.2012.1214.75918,1110.604.35%
3 Months12.0118.6710.3714.32873,2452.3719.73%
6 Months7.5622.006.3513.14955,0696.8290.21%
1 Year8.2622.005.7511.06790,7716.1274.09%
3 Years2.2522.000.81656.94601,68512.13539.11%
5 Years16.0022.000.81655.88898,135-1.62-10.13%

Cel Sci Description

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.